Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Inhibitors of the enzyme prolyl oligopeptidase (PO) improve performance in rodent learning and memory tasks. PO inhibitors are also implicated in the action of drugs used to treat bipolar disorder: they reverse the effects of three mood stabilizers on the dynamic behaviour of neuronal growth cones. PO cleaves prolyl bonds in short peptides, suggesting that neuropeptides might be its brain substrates. PO is located in the cytosol, however, where it would not contact neuropeptides. Here, we show that mice with a targeted PO null-mutation have altered growth cone dynamics. The wild-type phenotype is restored by PO cDNAs encoding either native or a catalytically-dead enzyme. In addition, we show that PO binds to the growth-associated protein GAP-43, which is a key regulator of synaptic plasticity. Taken together, our results show that peptidase activity is not required for PO function in neurons and suggest that PO instead acts by binding to cytosolic proteins that control growth cone and synaptic function.

Original publication

DOI

10.1016/j.mcn.2009.03.003

Type

Journal article

Journal

Mol Cell Neurosci

Publication Date

07/2009

Volume

41

Pages

373 - 382

Keywords

Animals, Antimanic Agents, Carbamazepine, Cell Culture Techniques, DNA, Complementary, GAP-43 Protein, Growth Cones, Humans, Indoles, Lamotrigine, Lithium Chloride, Mice, Mice, Knockout, Phosphatidylinositols, Rats, Serine Endopeptidases, Thiazolidines, Triazines, Valproic Acid